Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 7 280 persons.
Sales per Businesses
20162017Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical Business431,701100%423,977100% -1.79%
Sales per Regions
20162017Delta
JPY (in Million)%JPY (in Million)%
Japan314,76472.9%320,36975.6% +1.78%
Europe66,96215.5%57,42513.5% -14.24%
North America31,0437.2%27,0396.4% -12.9%
Asia18,5074.3%18,7524.4% +1.32%
Other425.000.1%392.000.1% -7.76%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD632007Executive President & Representative Director
Michihiro Tsuchiya, PhD701976Chairman
Eizou Tabaru592014Director, IR Contact, Manager-Finance & Accounting
Yoshiaki Ishizaki622007Director, Managing Executive Officer & GM-Sales
Seiichi Murakami601980Director & Head-External Affairs
Takashi Kobayashi621980Director, Managing Executive Officer & Head-Tokyo
Shigehiko Hattori762011Independent Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Tetsuo Yoshikawa--Executive Officer & Manager-Kyushu Branch Sales
Shigeki Nakata--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 234,969,970 41.9% 430,012 0.1% 41.9%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
BlackRock Fund Advisors 6,010,400 1.07%
The Vanguard Group, Inc. 5,428,764 0.97%
Norges Bank Investment Management 4,460,317 0.79%
Nomura Asset Management Co., Ltd. 3,976,300 0.71%
Nipro Corp. 3,821,700 0.68%
APG Asset Management NV 3,272,685 0.58%
Mellon Capital Management Corp. 1,851,277 0.33%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1911.50%51,632,061 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%40,932,616 USD
Medipal Holdings Corp (7459) 2,125,7320.87%38,880,531 USD
VITAL KSK HOLDINGS INC (3151) 1,455,2962.38%11,642,892 USD
Mitsubishi Tanabe Pharma Corp (4508) 429,7000.077%10,223,822 USD
T&D Holdings Inc (8795) 572,5000.084%8,455,768 USD
HOKUYAKU TAKEYAMA Holdings,Inc. (3055) 1,176,3424.71%7,047,724 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%4,192,045 USD
KOEI CHEMICAL COMPANY, LIMITED (4367) 910,0003.71%4,043,712 USD
Create SD Holdings Co Ltd (3148) 3,6000.0054%90,933 USD
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MITSUBISHI TANABE PHARMA CORP13.65%13 347
JOHNSON & JOHNSON15.12%355 979
NOVARTIS8.84%216 915
ROCHE HOLDING LTD.4.99%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705
SANOFI6.97%122 127
BAYER8.85%104 602
GLAXOSMITHKLINE-4.61%94 281
BRISTOL-MYERS SQUIBB COMPANY-2.86%92 525
NOVO NORDISK A/S14.64%88 994
ELI LILLY AND COMPANY4.79%84 853
ABBOTT LABORATORIES26.89%84 683
ALLERGAN PLC6.66%74 881
ASTRAZENECA0.21%72 406
SHIRE-19.63%43 974
TAKEDA PHARMACEUTICAL CO LTD21.76%42 619
ASTELLAS PHARMA INC-15.07%26 156
JIANGSU HENGRUI MEDICINE CO., LTD17.78%22 683
CHUGAI PHARMACEUTICAL CO LTD28.02%22 007
SHIONOGI & CO LTD1.73%17 154
Connections : Mitsubishi Tanabe Pharma C
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2017 People , Fundamentals and Ownership